Published EU Acts

Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices

Further information on the Act can be found below:

EU Act: Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices [EXTERNAL LINK]

Date of Notification to Windsor Framework Democratic Scrutiny Committee (DSC): 11 July 2024

Date published in Official Journal of the EU: 9 July 2024

Status: No Inquiry

Departmental assessment of impact: Departmental Initial Assessment of Impact (PDF, 4 pages, 200KB)

DSC Decisions: At its meeting of 18 July 2024, the Committee decided not to hold an inquiry into the replacement EU act, pursuant to paragraph 8(1) of Schedule 6B of the Northern Ireland Act.

Further information on the Act can be found below:

UK Government Explanatory Memorandum - 14 May 2024 [PDF, 4 Pages, 102kb]